TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice
Crossref DOI link: https://doi.org/10.1007/s00262-015-1730-4
Published Online: 2015-06-20
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koga-Yamakawa, Erina
Murata, Masashi
Dovedi, Simon J.
Wilkinson, Robert W.
Ota, Yosuke
Umehara, Hiroki
Sugaru, Eiji
Hirose, Yuko
Harada, Hideyuki
Jewsbury, Philip J.
Yamamoto, Setsuko
Robinson, David T.
Li, Chiang J.
Text and Data Mining valid from 2015-06-20